Search

Search Constraints

You searched for: Author/Creator Lopalco, Giuseppe

Search Results

62. Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study. (18th August 2015)

63. SAT0240 DEVELOPMENT AND PRELIMINARY VALIDATION OF THE BEHÇET'S SYNDROME OVERALL DAMAGE INDEX (BODI). (June 2019)

64. SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS. (June 2019)

65. Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study. Issue 12 (18th July 2022)

67. Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis. (2nd January 2019)

68. The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease. (17th February 2020)

69. THU0299 PATIENT GLOBAL ASSESSMENT OF DISEASE ACTIVITY IN BEHÇET'S SYNDROME: A MULTICENTER STUDY. (June 2019)